An Official Website of the United States Government
Company Information:
Name:
21ST CENTURY THERAPEUTICS, INC.
Address:
52623 SEVEN OAKS DR
SHELBY TOWNSHIP, MI 48316-2990
SHELBY TOWNSHIP, MI 48316-2990
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Novel Small-molecule TNF-a Modulators as Chemoprotective Agents
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Jiajiu Shaw
Award Amount:
$154,852.00
Abstract:
DESCRIPTION (provided by applicant): Cisplatin is a widely used cytotoxic agent with therapeutic activity against various tumors, but also with substantial side effects, including nephrotoxicity, hepatotoxicity and myelosuppression. Therefore, a chemoprote
ctive agent which reduces the side effects… More
Novel small-molecule TNF-a modulators as chemoprotective agents
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Jiajiu Shaw – 313-870-1741
Award Amount:
$1,133,678.00
Abstract:
DESCRIPTION (provided by applicant): Cisplatin is a widely used cytotoxic agent with therapeutic activity against various tumors, but also with substantial side effects, including nephrotoxicity, hepatotoxicity and myelosuppression. Therefore, a chemoprotective agent which reduces the side effects… More
TAS::75 0849::TAS
Award Year / Program / Phase:
2011 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Jiajiu Shaw – 313-874-6798
Award Amount:
$186,857.00
Abstract:
Radiotherapy can potentially inflict serious damage on healthy normal organs. For example, pneumonitis and fibrosis are two well-recognized adverse effects from lung cancer radiotherapy: Currently, amifostine (Ethyol) is the only approved radioprotector indicated to reduce xerostomia associated with… More